HOME >> MEDICINE >> NEWS
Lilly studies try to shed light on impact of race

CHICAGO, June 1, 2007 -- Statistics show lung cancer is the leading cause of cancer death in African-Americans, with 21,550 new cases expected to be diagnosed and 16,700 deaths expected this year. Equally devastating, lung cancer is the leading cause of cancer death in Hispanic men and the second leading cause of cancer death in Hispanic women. Researchers at Eli Lilly and Company are actively investigating the efficacy and safety of lung cancer treatments ALIMTA (pemetrexed for injection) and GEMZAR (gemcitabine HCl for injection) in treating non-small cell lung cancer (NSCLC) in African-Americans, Hispanics and other diverse populations.

Two retrospective Lilly studies were unveiled today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. They offered cursory insight into how a diverse group of patients respond to treatment with Lilly chemotherapeutic options. One study analyzed data of chemonave African-American patients with stage IIIB/IV NSCLC treated with GEMZAR in combination with carboplatin or paclitaxel (Taxol) versus patients taking carboplatin in combination with paclitaxel. The second study provided data from six previous trials for non-Caucasian patients with advanced or metastatic NSCLC treated with ALIMTA.

African-Americans are often underrepresented in clinical trials and, therefore, little is known about the possible impact of race on the utility of many medications, said Coleman Obasaju, M.D., Ph.D., United States oncology medical director of Lilly and the principal investigator of these two studies. Because lung cancer is a particularly devastating disease, and a growing concern in the African-American population, it was a logical starting point for our analysis.

The GEMZAR study released at ASCO analyzed overall survival data from a previous randomized Phase III trial in the treatment of NSCLC, viewing data outcomes and toxicity data of 128 African-Americans compa
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
1-Jun-2007


Page: 1 2 3

Related medicine news :

1. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
2. Lilly Foundation gift to Indiana University Cancer Center
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. International studies show high efficacy for HPV vaccine
5. Innovative device to treat brain cancer shows promise in early studies
6. Limiting eligibility for medical studies can omit women and African-Americans
7. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
8. DOE commits $27.5M for uranium contaminant transport field studies
9. Clinical studies evaluate potential treatments for mouth ulcers
10. Call for greater use of comparative effectiveness studies to help advance disease management
11. Americans still not eating enough fruits and vegetables, according to 2 recent studies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/15/2019)... ... May 15, 2019 , ... Benchmark , a human ... announced that its founder, chairman and CEO, Tom Grape, has received the Massachusetts ... pioneering efforts over the last 30 years, which have led to the establishment ...
(Date:5/15/2019)... GRANTS PASS, Ore. (PRWEB) , ... May 15, ... ... Steven Rotter, M.D., Internal Medicine, Oregon & Nancy Yonally Coleman, Corporate trainer and ... The opioid crisis in America and globally was the subject of intense discussion ...
(Date:5/14/2019)... Mich. (PRWEB) , ... May 15, 2019 , ... Women’s ... Michigan. The team of Midwives at Women’s Excellence specialize in prenatal care and ... Bow Pointe Drive, Suite 380 Clarkston, MI 48346. The main Clarkston office for ...
(Date:5/14/2019)... (PRWEB) , ... May 14, 2019 , ... ... information technology services to the healthcare industry, announced today that John Stanley, Vice ... Consulting magazine. Stanley, Impact’s Market Leader for the Western U.S., has been recognized ...
(Date:5/14/2019)... ... ... A high number of HIV cases among the LGBTQ community’s African-American and Hispanic ... the southern United States. Specifically, the sub-groups at greater risk of acquiring HIV ... transgender people of color ages 13 to 34. In response, the Houston Health ...
Breaking Medicine News(10 mins):
(Date:5/15/2019)... ... May 15, 2019 , ... Claudius Moore, a seasoned ... President of Information Technology. Over the last 15 years, Moore has mastered a ... while also creating a high-quality, efficient experience for patients. , Moore will lead ...
(Date:5/15/2019)... ... May 15, 2019 , ... Yesterday FeaturedCustomers ... to give prospects better insight on which Emergency Mass Notification Software would work ... vendors according to the 2019 Spring Emergency Mass Notification Software Customer Success Report ...
(Date:5/15/2019)... ... May 15, 2019 , ... PAINWeekEnd on June 22 at ... will be an educational and exciting program providing busy clinicians and allied healthcare ... pain. , In Rhode Island, updated regulations intended to make the prescribing ...
Breaking Medicine Technology:
Cached News: